James Caruso V.'s most recent trade in Cellectar Biosciences Inc was a trade of 10,000 Warrants done . Disclosure was reported to the exchange on July 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cellectar Biosciences Inc | James Caruso V. | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 02 Jul 2025 | 10,000 | 10,000 | - | - | Warrants | |
| Cellectar Biosciences Inc | V. Caruso James | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.99 per share. | 02 Jul 2025 | 10,000 | 11,638 (0%) | 0% | 5.0 | 49,900 | Common Stock |
| Cellectar Biosciences Inc | James V. Caruso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 900,000 | 900,000 | - | - | Stock option (right to buy) | |
| Cellectar Biosciences Inc | James V. Caruso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 900,000 | 900,000 | - | - | Stock option (right to buy) | |
| Cellectar Biosciences Inc | Caruso V. James | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 261,000 | 261,000 | - | - | Stock option (right to buy) | |
| Cellectar Biosciences Inc | Caruso V. James | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 40,596 | 49,236 (0%) | 0% | 0 | Common Stock | |
| Cellectar Biosciences Inc | James V. Caruso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 261,000 | 261,000 | - | - | Stock option (right to buy) | |
| Cellectar Biosciences Inc | James V. Caruso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 1,419,000 | 1,419,000 | - | - | Stock option (right to buy) |